about
Amyloidosis in Retinal Neurodegenerative DiseasesMitochondrial dysfunction: different routes to Alzheimer's disease therapyExpression profiling reveals differential gene induction underlying specific and non-specific memory for pheromones in mice.Chronic divalproex sodium use and brain atrophy in Alzheimer diseaseA non-enzymatic function of 17beta-hydroxysteroid dehydrogenase type 10 is required for mitochondrial integrity and cell survival.Docking Studies and Biological Evaluation of a Potential β-Secretase Inhibitor of 3-Hydroxyhericenone F from Hericium erinaceus.The novel amyloid-beta peptide aptamer inhibits intracellular amyloid-beta peptide toxicitySynapses, synaptic activity and intraneuronal abeta in Alzheimer's disease.Potential therapeutic benefits of strategies directed to mitochondria.Decreased proteolytic activity of the mitochondrial amyloid-β degrading enzyme, PreP peptidasome, in Alzheimer's disease brain mitochondriaEarly deficits in synaptic mitochondria in an Alzheimer's disease mouse modelAmyloid beta-protein assembly and Alzheimer disease.Mitochondrial energy failure in HSD10 disease is due to defective mtDNA transcript processingAβ oligomers-induced toxicity is attenuated in cells cultured with NbActiv4™ mediumMitochondrial transcript maturation and its disordersGinsenoside Rg1 attenuates oligomeric Aβ(1-42)-induced mitochondrial dysfunction.Inhibition of amyloid-beta (Abeta) peptide-binding alcohol dehydrogenase-Abeta interaction reduces Abeta accumulation and improves mitochondrial function in a mouse model of Alzheimer's diseaseOverexpression of amyloid-β protein precursor induces mitochondrial oxidative stress and activates the intrinsic apoptotic cascadeIdentification of a Small Molecule Cyclophilin D Inhibitor for Rescuing Aβ-Mediated Mitochondrial DysfunctionAmyloid precursor protein transgenic mouse models and Alzheimer's disease: understanding the paradigms, limitations, and contributions.Inhibition of ERK-DLP1 signaling and mitochondrial division alleviates mitochondrial dysfunction in Alzheimer's disease cybrid cellNeurotoxicity of amyloid β-protein: synaptic and network dysfunction.Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer's disease and Parkinson's diseaseProtective Effects of 6-(Methylsulfinyl)hexyl Isothiocyanate on Aβ-Induced Cognitive Deficit, Oxidative Stress, Inflammation, and Apoptosis in Mice
P2860
Q26739839-D85309CD-150C-4F02-905D-DCDE187488D0Q27009475-A689A9FA-2805-4FCB-80AB-C3B63E7DEDEAQ30424356-A75BF621-3F7E-4FD7-BF11-074A33551073Q30424864-A9434DED-4EA7-4C17-9B8F-2A72FAEA84ADQ30981928-4E9F7A42-EACB-4F83-803C-A9E65CD8E836Q33665730-71520643-AD27-4A38-9D43-1BDC0FE990DEQ33936364-79C94793-BAEB-4990-B54A-D4F6C4A5CDB9Q34028039-CBDCBE26-E444-44A2-BB21-AD79024430C7Q34117168-B1ADE39C-DC76-43F4-8EF3-73CFFF472FEDQ34199931-6B33F1CC-5BE0-4A49-BC6A-9DF3C4BCBC9AQ34276376-4F6B4044-FBBB-461A-900B-C44C83B1531BQ34849544-EE8891C6-4B5D-49D2-BC2F-E6F21ECE6E2BQ35164346-649DA623-4052-4BFD-8DD7-9CEA71AC4AF0Q35327150-860455BB-3F99-4B0D-B852-30C64487C2CAQ35825874-9BBA3496-8DDC-446B-A409-92B1C7D7579DQ36054716-0F6E8EE9-3254-47FF-B998-98CE4BC5D7B2Q36054722-22F6FBE2-6A37-487D-B15A-C90198F66B9BQ36371958-13397834-4A50-4613-B41C-54AF5C9AFC35Q36681747-A834D8A4-41EF-4A93-A898-D4B4FE0F77D5Q37247201-27440199-2387-421F-98C3-9BF33813C1F7Q37709664-73EDF651-4C64-4E40-94E2-3220872DCAD5Q38023860-2FC93DDB-A2CE-484C-9301-AA4A08E446C8Q39205712-C7E9EC5C-9395-4D8A-8CAB-6B83B9945401Q56364791-EC5E49E9-9348-47EF-839A-AD5DE1059758
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Amyloid-beta-induced mitochondrial dysfunction.
@en
type
label
Amyloid-beta-induced mitochondrial dysfunction.
@en
prefLabel
Amyloid-beta-induced mitochondrial dysfunction.
@en
P2860
P1476
Amyloid-beta-induced mitochondrial dysfunction.
@en
P2093
John Xi Chen
Shi Du Yan
P2860
P304
P577
2007-09-01T00:00:00Z